Release Date: 24/07/12 09:52 Summary: Boardroom Radio Interview Price Sensitive: No Download Document 328.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%